NICE turns down Bayer’s Stivarga for liver cancer

8th November 2017 Uncategorised 0

Bayer’s Stivarga is not being recommended by NHS treatment cost regulators for certain patients with advanced unresectable hepatocellular carcinoma.

More: NICE turns down Bayer’s Stivarga for liver cancer
Source: News